Topics
March 2013 | Special Cover Features: Medical Innovation In Retina
Integrin Peptide Therapy for the Treatment of Vascular Eye Diseases
In addition to its effects in DME, this molecule can induce posterior vitreous detachment.
Baruch D. Kuppermann, MD, PhD
May 14, 2026
Topcon Expands ARVO Presence with Record Research Activity
May 13, 2026
NeuroVision Acquires Durin Life Sciences to Expand Neurodegenerative Disease Diagnostics Platform
Study: Popular GLP-1 Drugs Linked to Certain Optic Nerve Disorders
May 12, 2026
Astellas Presents New Izervay Data Showing Reduced Risk of Losing Driving Eligibility in GA Patients
April 2026 Insert
Editorially independent supported by Abbvie and Regenxbio
April 2026 Supplement
Editorially independent content supported with advertising by EyePoint
Free Print Subscription
Email Newsletter
Conference Calendar
